Mevox
PrivateLast Round
Series A
Feb 11, 2021
Total Funding Raised
$6.08M
Company Overview
Mevox is a pharmaceuticals and biotechnology company that develops optimized protein vaccines designed to induce higher antibody levels.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2G
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mevox Comparables
Compare Mevox with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Baseimmune | 79% | |
| Lovaltech | 77% | |
| SpyBiotech | 75% |
Mevox Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 11, 2021 |
Mevox Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Morningside Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 11, 2021
$6M round led by Morningside Ventures.
Mevox Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access